CNBC’s Jim Cramer said Tuesday that investors need to look beyond artificial intelligence trading.
“There’s more to life and investing than data centers,” the “Mad Money” host said. “The endless focus on data centers and anti-data center backlash is driving opportunity after opportunity away from data centers, and I will no longer allow you to miss out on them.”
AI infrastructure stocks have soared this year, but many have fallen in recent weeks. Kramer hasn’t abandoned the deal, but said investors are so focused on one of the hottest themes in the market that they’re overlooking opportunities in other areas. He said he expects the volatility in AI build stocks to continue at least until after the November midterm elections.
“It’s no use loading the boat,” he said. “It’s better to take a few chances and then look elsewhere for the many opportunities that are in front of you.”
Kramer first pointed to aerospace. ge aerospace announced Tuesday it will spend nearly $12 billion to acquire aerospace casting supplier Consolidated Precision Products, a move he said will strengthen the engine maker’s supply chain and help accelerate production. he said it might also be beneficial boeingis a major customer of GE and needs to increase production to meet a large backlog of orders.
In fintech, Kramer emphasized trading platforms. robin hood Buy now, pay later company affirm. While Robinhood has benefited from the strength of the crypto and prediction markets, Cramer said the bigger story is that it is attracting younger customers. He also likes Affirm, which has 28 million active customers and partners with major companies, including: Amazon, costco, walmart and apple.
Healthcare offers additional opportunities, he said. Kramer pointed out that Hinge healthIt is primarily a digital platform for physical therapy, but also has ambitions for other areas of healthcare. medtronicbetter-than-expected results and improved organic growth failed to meaningfully boost the stock price.
“The stock is now where it was when it was reported,” Cramer said of medical device maker Medtronic. “That’s strange.”
Kramer also likes the energy infrastructure, emphasizing: enbridge and enterprise product partner. Both offer dividend yields above 5% and could benefit from changing energy flows amid the turmoil around the Strait of Hormuz.
Finally, Kramer pointed to biopharmaceutical giants. amgenHe acknowledged that “a little bit of fortitude” was needed after Tuesday’s 10% drop. NovartisCholesterol drug fails late-stage cardiovascular health test. Amgen has a rival drug in clinical trials, explaining why its stock has fallen in line with Novartis. But Mr. Kramer said Amgen’s candidate is a little different, and many of the risks may have already been priced in after the stock price tumbled.
“I’m not saying all of these ideas are better than data center-related ideas,” Cramer said. “I think the next two months will be a happier and more profitable time for you if you diversify away from all the data center stuff.”
